Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate
Prostate Cancer
-
-
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
-
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
-
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
-
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
-
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
-
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
-
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
-
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
Categories
Alliance Committee
Browse by Year